Snapshot from Aug 24, 2026 at 07:00 UTC. For live data and tracking: View Live
Tech medical research

Volatility Priors Linked to Delusion Recovery

Analysis based on 6 articles · First reported Aug 18, 2026 · Last updated Aug 20, 2026

Sentiment
10
Attention
2
Articles
6
Market Impact
General
Live prominence charts, article sentiment distribution, and event development timeline available on the Ergen Dashboard

The study could influence future development of psychological and pharmacological treatments for schizophrenia, potentially benefiting pharmaceutical and biotech companies focused on psychiatric disorders. However, as early-stage research, immediate market impact is limited, though it may boost interest in computational psychiatry approaches.

Healthcare Pharmaceuticals Biotechnology

A study published in Biological Psychiatry: Cognitive Neuroscience and Neuroimaging, led by Cuy Sheffield of Vanderbilt University Medical Center, found that reductions in volatility priors - the brain's expectations about environmental unpredictability - were significantly associated with improvements in delusion severity among patients with schizophrenia-spectrum disorders recovering from acute psychotic episodes. The six-month longitudinal study of 75 patients and 71 controls showed that elevated volatility priors at baseline declined over time in parallel with reduced delusional thinking and paranoia, suggesting they are a modifiable state marker rather than a fixed trait. The findings point to a potential new treatment target for delusions, complementing existing antipsychotic medications. The research was funded by the United States — National Institute of Mental Health and published by Elsevier.

60 Elsevier published study
per
Lead investigator who designed and led the study; her work may advance her career and influence future research directions.
Importance 85.0 Sentiment 10.0
priv
Publisher of the journal where the study appeared; the publication reinforces its position in scientific literature.
Importance 60.0 Sentiment 5.0
govactor
Provided grant funding for the research, supporting the study's execution and contributing to its success.
Importance 50.0 Sentiment 5.0
per
Editor-in-Chief of the journal; commented on the significance of the findings, adding credibility to the publication.
Importance 30.0 Sentiment 5.0
ngo
Sponsor of the journal; the study aligns with its mission and may increase its visibility.
Importance 25.0 Sentiment 5.0
stock
Parent company of Elsevier; the publication may marginally enhance its portfolio of scientific content.
Importance 20.0 Sentiment 5.0
ERGEN INTELLIGENCE
Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.